Question explored with the scientific record
are there any ways to avoid cancer
The short version: yes, lifestyle changes and screening meaningfully reduce your cancer risk, but the evidence is stronger for some cancers than others.
The evidence is clearest for smoking. The Swedish cohort study [1] found that stopping smoking in middle age cut cancer risk by about a third (HR 0.64). The Peru study [4] attributed 7.2% of all cancer cases and deaths to tobacco alone. If you smoke, quitting is the single biggest lever you have.
Diet and exercise also matter, though the numbers are smaller. The same Swedish study [1] found that each one-point improvement in a six-point lifestyle score (covering diet, alcohol, physical activity, smoking, and body weight) lowered cancer risk by 10-19%. The DIANA-5 trial [2] showed that a structured diet-and-exercise program in high-risk breast cancer patients produced meaningful weight loss (-2.4 kg vs -1.0 kg) and lower triglycerides, though final recurrence data is still pending. The Mediterranean diet [7] was linked to lower prostate cancer mortality (HR 0.78) and trends toward lower bladder cancer risk.
Screening works for several cancers, but the benefit is modest and comes with real costs. The table below shows the mortality reduction from screening for the cancers with the strongest evidence:
| Cancer type | Screening method | Mortality reduction | Number needed to screen |
|---|---|---|---|
| Breast (ages 50-69) | Mammography | 22% (RR 0.78) [9] | ~400 over 10 years to save one life [18] |
| Lung (high-risk) | Low-dose CT | 20% relative reduction [14] | 320 |
| Colorectal | Sigmoidoscopy | ~28% fewer deaths [10] | Not reported in study |
| Cervical | Pap smear | 70% reduction in screened vs unscreened [11] | Not reported in study |
| Gastric (Japan) | Endoscopy | 67% reduction vs X-ray [12] | Not reported in study |
The catch: screening detects cancers that would never have killed you. Mammography, for example, increases breast cancer diagnoses by about 50% [18], and some of those are overdiagnosis. You trade one harm (unnecessary treatment) for another (a prevented death). The trade is worth it for some age groups but not others.
My call: for a middle-aged adult who does not smoke, eats a Mediterranean-style diet, maintains a healthy weight, and gets screened for breast, colorectal, and cervical cancer at recommended intervals, the evidence supports a meaningful reduction in cancer risk. Confidence: moderate — the evidence is consistent but mostly observational, and the absolute risk reduction for any single intervention is small.
Sources examined 21
-
Impact of achievement and change in achievement of lifestyle recommendations in middle-age on risk of the most common potentially preventable cancers
In a Swedish population-based cohort, the study shows that higher average adherence to lifestyle recommendations over a decade in middle age is linked to a lower risk of the most common potentially preventable cancers in both men and women, while within-person changes in adheren…
DOI: 10.1016/j.ypmed.2021.106712 -
1181 Content Validity of the Sexual Concerns Questionnaire-Gynecological Cancer
DIANA-5 is a multicenter randomized controlled trial assessing whether a lifestyle intervention combining dietary changes and physical activity can reduce breast cancer recurrences in high-risk patients, with interim results showing greater weight loss and triglyceride reduction…
DOI: 10.1016/s0959-8049(12)71775-6 -
Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case–control study
This nested case-control study investigates the association between metabolic syndrome and breast cancer risk in postmenopausal women, finding that metabolic syndrome significantly increases the risk of breast cancer, particularly through low HDL-cholesterol and high triglycerid…
DOI: 10.1016/j.numecd.2009.02.006 -
Proportion of cancer cases and deaths attributable to potentially modifiable risk factors in Peru
Peru's 2018 cancer burden is largely driven by modifiable factors, with 38.5% of new cancer cases and 43.4% of cancer deaths attributable to preventable risks, led by oncogenic infections (HPV, H. pylori, EBV) and unhealthy lifestyles, underscoring vaccination and lifestyle inte…
DOI: 10.1186/s12885-024-12219-4 -
Lactose intolerance: Perceptions, scientific realities and management
This study explores the challenges and strategies for translating nutritional and lifestyle evidence into practice for cancer prevention and management, highlighting the need for effective communication and intervention methods.
DOI: 10.1016/j.jnim.2017.04.009 -
Lifestyle Intervention in Men with Advanced Prostate Cancer Receiving Androgen Suppression Therapy: A Feasibility Study
This feasibility study evaluates the impact of a 12-week lifestyle intervention combining supervised exercise and dietary advice on health outcomes in men with advanced prostate cancer undergoing androgen suppression therapy, showing significant improvements in exercise behavior…
DOI: 10.1158/1055-9965.epi-10-1143 -
Impact of a Mediterranean diet on prevention and management of urologic diseases
Adherence to a Mediterranean diet is linked to prevention and improvement of erectile dysfunction, lower urinary tract symptoms, and nephrolithiasis, with potential benefits for urologic cancers, but evidence quality and causality require further rigorous trials.
DOI: 10.1186/s12894-024-01432-9 -
Personalised risk-stratified approaches in prevention of cancer and other NCDs: The Joint Action PreventNCD project
This paper outlines the Joint Action PreventNCD project's strategy to develop and evaluate personalised, risk-stratified prevention approaches for cancer and other non-communicable diseases in Europe, combining literature reviews, ethics and social implications, public engagemen…
DOI: 10.1177/14034948251384404 -
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation
This systematic review and meta-analysis evaluates the effectiveness of mammography screening in reducing breast cancer mortality among average-risk women, updating the 2009 U.S. Preventive Services Task Force recommendations.
DOI: 10.7326/M15-0969 -
Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality
This study evaluates the effectiveness of flexible sigmoidoscopy screening on reducing colorectal cancer incidence and mortality in a population-based randomized clinical trial involving 100,210 individuals aged 50 to 64 years in Norway.
DOI: 10.1001/jama.2014.8266 -
Effectiveness of Cervical Cancer Screening Over Cervical Cancer Mortality Among Japanese Women
This study evaluates the effectiveness of cervical cancer screening in reducing cervical cancer mortality among Japanese women aged 30-79, finding a significant reduction in mortality associated with screening participation.
DOI: 10.1093/jjco/hyl060 -
Mortality reduction from gastric cancer by endoscopic and radiographic screening
This population-based cohort study evaluates the effectiveness of endoscopic screening in reducing gastric cancer mortality by 67% compared to radiographic screening in participants aged 40-79 in Tottori and Yonago, Japan.
DOI: 10.1111/cas.12829 -
Effectiveness and cost‐effectiveness of colorectal cancer screening: Selecting the ideal strategy
This study evaluates the effectiveness and cost-effectiveness of colorectal cancer screening strategies, advocating for annual faecal occult blood tests combined with periodic flexible sigmoidoscopy for average-risk individuals over 50 to significantly reduce mortality rates.
DOI: 10.1111/j.1440-1746.1998.tb01887.x -
A new era for lung cancer detection
The study evaluates the effectiveness of low-dose computed tomography (CT) screening in reducing lung cancer mortality compared to traditional radiography, demonstrating a significant reduction in lung cancer deaths and overall mortality among high-risk individuals.
DOI: 10.1016/s1548-5315(12)70137-7 -
Screening for Cervical Cancer
This study evaluates the effectiveness of cervical cancer screening, particularly through the Papanicolaou smear, in reducing the incidence and mortality of invasive cervical cancer, highlighting the significant benefits of regular screening for women aged 20 to 75.
DOI: 10.7326/0003-4819-113-3-214 -
Modeling the Cost-Effectiveness of Colorectal Cancer Screening: Policy Guidance Based on Patient Preferences and Compliance
This study develops an agent-based simulation model to evaluate the cost-effectiveness of colorectal cancer screening by incorporating real-world patient preferences and compliance, revealing that increasing compliance with both initial screening and diagnostic testing can signi…
DOI: 10.1158/1055-9965.EPI-09-0083 -
Biology of Epithelial Ovarian Cancer: Implications for Screening Women at High Genetic Risk
This study analyzes the clinicopathologic features of screen-detected ovarian cancers in women at both general population risk and high genetic risk, revealing that screening may not effectively reduce mortality in high-risk populations.
DOI: 10.1200/jco.2004.07.179 -
Screening for breast cancer in England: past and future
Population-based mammographic screening in England since 1988 reduces breast cancer mortality, saves about 1,400 lives annually, and influences incidence patterns, treatment choices, recall, and costs.
DOI: 10.1258/096914106777589678 -
Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
A large UK Biobank prospective study screened 28 biochemical biomarkers to identify associations with prostate cancer incidence and mortality, finding novel links with vitamin D, urea, and phosphate (positive) and with glucose, total protein, and AST (inverse), while evidence fo…
DOI: 10.1038/s41416-020-01081-3 -
Cholecystectomy and risk of pancreatic cancer: a meta-analysis of observational studies
This meta-analysis of 18 observational studies found that individuals with a history of cholecystectomy have a 23% increased risk of developing pancreatic cancer, independent of various confounding factors.
DOI: 10.1007/s10552-011-9856-y -
Prostate cancer - risk factors and prevention strategies
A narrative literature review analyzing modifiable and non-modifiable risk factors for prostate cancer and summarizing current prevention strategies, including evidence from chemoprevention and screening trials, with findings that lifestyle/genetic factors influence risk and tha…
DOI: 10.12775/jehs.2023.21.01.018